Laurion Capital Management LP Cardiff Oncology, Inc. Transaction History
Laurion Capital Management LP
- $5.37 Billion
- Q2 2025
A detailed history of Laurion Capital Management LP transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 1,797,282 shares of CRDF stock, worth $3.63 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,797,282
Previous 916,214
96.16%
Holding current value
$3.63 Million
Previous $2.88 Million
96.84%
% of portfolio
0.11%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding CRDF
# of Institutions
126Shares Held
25.8MCall Options Held
1.01MPut Options Held
293K-
Vanguard Group Inc Valley Forge, PA3.73MShares$7.53 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.63MShares$5.31 Million0.0% of portfolio
-
Blair William & CO Chicago, IL2.52MShares$5.1 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA1.5MShares$3.03 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.42MShares$2.87 Million0.01% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $87.5M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...